补体因子I(CFI)重组蛋白
Recombinant Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- 编号RPB978Hu01
- 物种Homo sapiens (Human，人)相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌, 细胞外基质
- 预测分子量28.8kDa
- 实际分子量30kDa(差异分析请参阅说明书)
- 片段与标签Ile340~Val583 with N-terminal His Tag
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性状冻干粉
- 纯度> 97%
- 等电点6.4
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 1032¥ 2580¥ 5160¥ 15480¥ 38700
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
SDS-PAGE图
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPB978Hu02 | 补体因子I(CFI)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB978Hu01 | 补体因子I(CFI)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB978Hu01 | 补体因子I(CFI)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB978Hu02 | 补体因子I(CFI)多克隆抗体 | WB; IHC; ICC; IP. |
| MAB978Hu22 | 补体因子I(CFI)单克隆抗体 | WB; IHC; ICC; IP. |
| WEB978Hu | 补体因子I(CFI)检测试剂盒(酶联免疫吸附试验法,宽范围) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB978Hu | 补体因子I(CFI)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB978Hu | 补体因子I(CFI)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes[PubMed: 26613809] |
| Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series[PubMed: 25443527] |
| United States Patent Application | NOVEL ASSAY[y2016:139118] |
| Researchgate | Compliment factor i bioassay[US20170285024] |
| PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and …[Pubmed:29782502] |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H[33788378] |